Heart scan may spot hidden brain disease

NCT ID NCT05514106

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests whether a special heart scan using a radioactive drug called 123I-MIBG can help identify Lewy body disease, a type of dementia that also affects movement and sleep. Researchers will compare scan results with clinical diagnoses in 50 people who have conditions like dementia, Parkinsonism, mild cognitive impairment, or REM sleep behavior disorder. The goal is to see if the scan can improve prediction of the underlying disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a radioactive drug called 123I-MIBG, given once for a heart scan
What this could lead to
If it works, this scan could become a reliable tool to diagnose Lewy body disease earlier and more accurately.
What could go wrong
This is a small, early-phase study, so the scan may not prove accurate enough for routine use. The radioactive drug carries a small radiation risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.